Women's Cancer Research Foundation
Physical Activity and Gynecologic Cancer Outcomes
Physical activity is associated with improved cancer outcomes, but it is unclear which patients may benefit most from increased.....
top of page
The Way Forward Is Clearer, Together.
The Women’s Cancer Research Foundation (WCRF) annually publishes and funds numerous clinical studies on breast and gynecologic (ovarian, endometrial, and cervical) cancers. The WCRF’s oncology experts work tirelessly with the belief that each new clinical study has the potential to fundamentally improve the outcomes of patients diagnosed with breast and gynecologic cancers.
Search
Women's Cancer Research Foundation
Aug 31, 20221 min read
‘Drug factory’ Implants Eliminate Ovarian, Colorectal Cancer in Mice
Rice University bioengineers have shown they can eradicate advanced-stage ovarian and colorectal cancer in mice in as little as six days.
Women's Cancer Research Foundation
Aug 23, 20221 min read
Genetic Testing — A Game-Changer
Since 2003, when scientists successfully mapped the human genome, personalized cancer therapy has transformed cancer treatment.
Women's Cancer Research Foundation
Aug 1, 20221 min read
Malnutrition As A Risk Factor for Post-operative Morbidity in Gynecologic Cancer
An article from Gynecologic Oncology reviewed the association between various malnutrition definitions with post-operative morbidity.
Women's Cancer Research Foundation
Jul 26, 20222 min read
Prevention of Ovarian Cancer
Risk reduction for women who carry BRCA1/2 mutations can achieve a 95% reduced risk of ovarian cancer through a risk-reducing...
Women's Cancer Research Foundation
Jul 20, 20221 min read
Liquid Biopsy in Ovarian Cancer
In recent years there have been considerable efforts to develop a blood test or liquid biopsy...
Women's Cancer Research Foundation
Jul 11, 20222 min read
Risk of Peritoneal Cancer After Risk-Reducing Bilateral Salpingo-Oophorectomy for Women
The average lifetime risk of developing ovarian cancer risk for women who harbor a BRCA1 or BRCA2 pathogenic germline mutation is 44% & 17%
Women's Cancer Research Foundation
Jul 6, 20222 min read
Breast Cancer Surgery Choice May Affect Young Survivors’ Quality of Life
Women diagnosed with breast cancer who had one or both breasts surgically removed had lower scores on a quality-of-life survey.
Women's Cancer Research Foundation
Jun 28, 20222 min read
Daily Aspirin Offers No Benefit in Breast Cancer Survivors
A recent study reported that daily intake of aspirin does not appear to prevent a recurrence of invasive breast cancer.
Women's Cancer Research Foundation
Jun 24, 20222 min read
Impact of Care by Gynecologic Oncologists on Primary Ovarian Cancer Survival: Population-based Study
Prompt treatment of advanced-stage ovarian cancer by a gynecologic oncologist with a combination of surgery and chemotherapy is approved...
Women's Cancer Research Foundation
Jun 15, 20222 min read
Contraceptive Use and the Risk of Ovarian Cancer Among Women With a BRCA1 or BRCA2 Mutation
Women with a BRCA1 and BRCA2 mutation have a higher lifetime risk of developing ovarian cancer.
Women's Cancer Research Foundation
May 20, 20221 min read
Ovarian Cancer Incidence and Death in Women Undergoing Bilateral Salpingo-Oophorectomy
Magnitude of risk reduction obtained with bilateral salpingo-oophorectomy remains unclear and must be weighed against the potential risks of
Women's Cancer Research Foundation
May 18, 20222 min read
A 2022 Physician's Guide to Hopes and Challenges of Cervical Cancer Eradication
Each year more than 14,000 women in the United States will be diagnosed with cervical cancer and more than 4,000 people will die from it.
Women's Cancer Research Foundation
May 16, 20222 min read
When Ovarian Cancer Returns, Surgery May Be a Good Choice for Selected Patients
A recent clinical trial revealed that a secondary surgery followed by chemotherapy can improve survival compared to chemotherapy alone.
Women's Cancer Research Foundation
Apr 25, 20222 min read
New Drug Combination Shown to be Effective for Patients with Advanced Ovarian Cancer
Ovarian cancer is the most lethal gynecologic malignancy. Novel approaches for relapsed ovarian cancer are necessary to improve survival.
Women's Cancer Research Foundation
Apr 22, 20222 min read
Clinical Characteristics, Pregnancy Outcomes & Ovarian Function - A Retrospective Age-Matched Study
Researchers evaluated the prognosis and pregnancy outcomes of pregnancy-associated breast cancer, a rare disease with increasing incidence.
Women's Cancer Research Foundation
Apr 19, 20221 min read
Lighting the Way for Improved Detection of Ovarian Cancer
Pafolacianine, an imaging drug that can help surgeons identify ovarian cancer lesions, has recently been accorded FDA approval.
Women's Cancer Research Foundation
Apr 11, 20221 min read
Breast Cancer and Community-Based Oncology Depression Screening Program
Researchers sought to examine if a greater proportion of breast cancer referrals to behavioral health could be achieved for patients in...
Women's Cancer Research Foundation
Apr 7, 20221 min read
Cancer Risks Associated with BRCA1 and BRCA2 Pathogenic Variants
In a recent study, age-specific risk estimates of cancers, excluding breast and ovarian cancer, associated with pathogenic variants in...
Women's Cancer Research Foundation
Apr 5, 20221 min read
Human Papillomavirus Infection Determines Prognosis in Cervical Cancer
Clinical research has identified a strong association between the detection of human papillomavirus (HPV) and invasive cervical cancer...
bottom of page